Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhongcai Yao

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|July 2, 2026
IRF4 transcriptionally activates CD36 to regulate glycolysis and suppress oxaliplatin resistance in colorectal cancerQing Sun, Dongliang Zhao, Zhongcai Yao, et al.
Frontiers in Psychiatry|April 10, 2024
Depression and hepatobiliary diseases: a bidirectional Mendelian randomization studyYu Kong, Zhongcai Yao, Lingli Ren, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cellsRong Bian, Jinkai Zhao, Zhongcai Yao, et al.
International Journal of Clinical and Experimental Pathology|January 18, 2020
Schisandrin B attenuates lipopolysaccharide-induced activation of hepatic stellate cells through Nrf-2-activating anti-oxidative activityZhongcai Yao, Jibo Han, Shuyi Lou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|July 2, 2026
IRF4 transcriptionally activates CD36 to regulate glycolysis and suppress oxaliplatin resistance in colorectal cancerQing Sun, Dongliang Zhao, Zhongcai Yao, et al.
Frontiers in Psychiatry|April 10, 2024
Depression and hepatobiliary diseases: a bidirectional Mendelian randomization studyYu Kong, Zhongcai Yao, Lingli Ren, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cellsRong Bian, Jinkai Zhao, Zhongcai Yao, et al.
International Journal of Clinical and Experimental Pathology|January 18, 2020
Schisandrin B attenuates lipopolysaccharide-induced activation of hepatic stellate cells through Nrf-2-activating anti-oxidative activityZhongcai Yao, Jibo Han, Shuyi Lou, et al.
Pageof 1